000 | 01329 a2200253 4500 | ||
---|---|---|---|
008 | 051207s xx 000 0 eng | ||
022 | _a1522-3191; | ||
050 | _aAC1.S5 | ||
082 | _a050 | ||
100 | _aSchmit, Julie, | ||
245 | 0 |
_aFDA Races to Keep Up with Misleading Drug Ads. _cJulie Schmit. |
|
260 |
_bUSA Today, _c2005. |
||
440 |
_aSIRS Enduring Issues 2006. _nArticle 74, _pBusiness, _x1522-3191; |
||
500 | _aArticles Contained in SIRS Enduring Issues 2006. | ||
500 | _aOriginally Published: FDA Races to Keep Up with Misleading Drug Ads, May 30, 2005; pp. n.p.. | ||
520 | _a"Stop misleading the public. Tell the truth. The FDA is firing that doubled-barreled commandment more often when it spots misleading promotions for prescription drugs, a sign the agency is getting tougher on what the pharmaceutical industry does with the $9 billion a year it spends on marketing to consumers and doctors." (USA TODAY) The article discusses the FDA's tougher enforcement of drug marketing. | ||
599 | _aRecords created from non-MARC resource. | ||
650 |
_aAdvertising _xDrugs |
||
650 | _aPharmaceutical industry | ||
610 |
_aUnited States _bFood and Drug Adm. |
||
650 | _aVioxx | ||
710 |
_aProQuest Information and Learning Company _tSIRS Enduring Issues 2006, _pBusiness. _x1522-3191; |
||
942 | _c UKN | ||
999 |
_c36955 _d36955 |